These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29054602)

  • 41. Double Trouble? CMC with a Mutation in both AIRE and STAT1.
    Al Dhanhani H; Al Shehri T; Lilic D; Buddles M; Kisand K; Maccari ME; Leahy TR
    J Clin Immunol; 2018 Aug; 38(6):635-637. PubMed ID: 30054782
    [No Abstract]   [Full Text] [Related]  

  • 42. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
    Puel A; Cypowyj S; Bustamante J; Wright JF; Liu L; Lim HK; Migaud M; Israel L; Chrabieh M; Audry M; Gumbleton M; Toulon A; Bodemer C; El-Baghdadi J; Whitters M; Paradis T; Brooks J; Collins M; Wolfman NM; Al-Muhsen S; Galicchio M; Abel L; Picard C; Casanova JL
    Science; 2011 Apr; 332(6025):65-8. PubMed ID: 21350122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
    Peters A; Fowler KD; Chalmin F; Merkler D; Kuchroo VK; Pot C
    J Immunol; 2015 Nov; 195(9):4144-53. PubMed ID: 26408664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PD-L1 up-regulation restrains Th17 cell differentiation in
    Zhang Y; Ma CA; Lawrence MG; Break TJ; O'Connell MP; Lyons JJ; López DB; Barber JS; Zhao Y; Barber DL; Freeman AF; Holland SM; Lionakis MS; Milner JD
    J Exp Med; 2017 Sep; 214(9):2523-2533. PubMed ID: 28710273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gain-of-function STAT1 mutations are associated with intracranial aneurysms.
    Dadak M; Jacobs R; Skuljec J; Jirmo AC; Yildiz Ö; Donnerstag F; Baerlecken NT; Schmidt RE; Lanfermann H; Skripuletz T; Schwenkenbecher P; Kleinschnitz C; Tumani H; Stangel M; Pul R
    Clin Immunol; 2017 May; 178():79-85. PubMed ID: 28161409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-17 and infections.
    Ling Y; Puel A
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():34-40. PubMed ID: 25398490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bronchiectasis and Recurrent Respiratory Infections with a
    Huh HJ; Jhun BW; Choi SR; Kim YJ; Yun SA; Nham E; Kong T; Ki CS; Koh WJ
    Yonsei Med J; 2018 Oct; 59(8):1004-1007. PubMed ID: 30187709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucosal antifungal defence: IL-17 signalling takes centre stage.
    Glocker EO; Grimbacher B
    Immunol Cell Biol; 2011 Nov; 89(8):823-5. PubMed ID: 21577231
    [No Abstract]   [Full Text] [Related]  

  • 49. Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation.
    Sobh A; Chou J; Schneider L; Geha RS; Massaad MJ
    J Allergy Clin Immunol; 2016 Jul; 138(1):297-299. PubMed ID: 26948078
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunity to infection in IL-17-deficient mice and humans.
    Cypowyj S; Picard C; Maródi L; Casanova JL; Puel A
    Eur J Immunol; 2012 Sep; 42(9):2246-54. PubMed ID: 22949323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired STAT3-Dependent Upregulation of IL2Rα in B Cells of a Patient With a STAT1 Gain-of-Function Mutation.
    van Zelm MC; Bosco JJ; Aui PM; De Jong S; Hore-Lacy F; O'Hehir RE; Stirling RG; Cameron PU
    Front Immunol; 2019; 10():768. PubMed ID: 31068927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case Report: A New Gain-of-Function Mutation of
    Martinot M; Korganow AS; Wald M; Second J; Birckel E; Mahé A; Souply L; Mohseni-Zadeh M; Droy L; Tarabeux J; Okada S; Migaud M; Puel A; Guffroy A
    Front Immunol; 2021; 12():760019. PubMed ID: 34987506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review.
    Wang X; Zhao W; Chen F; Zhou P; Yan Z
    Mycopathologia; 2023 Apr; 188(1-2):87-97. PubMed ID: 36335528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation.
    Mössner R; Diering N; Bader O; Forkel S; Overbeck T; Gross U; Grimbacher B; Schön MP; Buhl T
    Clin Infect Dis; 2016 Apr; 62(7):951-3. PubMed ID: 26787170
    [No Abstract]   [Full Text] [Related]  

  • 55. Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation.
    Moriya K; Suzuki T; Uchida N; Nakano T; Katayama S; Irie M; Rikiishi T; Niizuma H; Okada S; Imai K; Sasahara Y; Kure S
    Int J Hematol; 2020 Aug; 112(2):258-262. PubMed ID: 32180118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-17 T cells' defective differentiation in vitro despite normal range ex vivo in chronic mucocutaneous candidiasis due to STAT1 mutation.
    Mekki N; Ben-Mustapha I; Liu L; Boussofara L; Okada S; Cypowyj S; Ghariani N; Saidi W; Denguezli M; Casanova JL; Puel A; Barbouche MR
    J Invest Dermatol; 2014 Apr; 134(4):1155-1157. PubMed ID: 24335902
    [No Abstract]   [Full Text] [Related]  

  • 57. STAT1 gain-of-function and chronic demodicosis.
    Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
    Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
    Ng WF; von Delwig A; Carmichael AJ; Arkwright PD; Abinun M; Cant AJ; Jolles S; Lilic D
    J Allergy Clin Immunol; 2010 Nov; 126(5):1006-15, 1015.e1-4. PubMed ID: 20934207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis.
    Bloomfield M; Zentsova I; Milota T; Sediva A; Parackova Z
    Front Immunol; 2022; 13():983977. PubMed ID: 36172362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Gain-of-Function Mutation in Stat1 Sumoylation Site Leads to CMC/CID Phenotype Responsive to Ruxolitinib.
    Al Shehri T; Gilmour K; Gothe F; Loughlin S; Bibi S; Rowan AD; Grainger A; Mohanadas T; Cant AJ; Slatter MA; Hambleton S; Lilic D; Leahy TR
    J Clin Immunol; 2019 Nov; 39(8):776-785. PubMed ID: 31512162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.